Borneol, an organic terpene derivative, presents anti-tumor activity in combination with cisplatin by triggering ferroptosis through NCOA4-mediated ferritinophagy, also leading to decreased expression of MES markers and enhanced expression of epithelial markers in non-small cell lung cancer (NSCLC) models88. This evidence concerns the gene NCOA4 and non-small cell lung carcinoma.